Predictors of response to botulinum toxin treatment in patients with primary hemifacial spasm: A prospective cohort study
Authors:
- Sneh JainSJSneh Jain
- Shweta PandeySPShweta Pandey
- Ravindra Kumar GargRGRavindra Kumar Garg
- Rajesh VermaRVRajesh Verma
- Hardeep Singh MalhotraHMHardeep Singh Malhotra
- Anit PariharAPAnit Parihar
- Praveen Kumar SharmaPSPraveen Kumar Sharma
- Neeraj KumarNKNeeraj Kumar
- Ravi UniyalRURavi Uniyal
- Imran RizviIRImran Rizvi
- Harish NigamHNHarish Nigam
- 17 March 2026
- journal article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 146, 108288
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Efficacy and safety of botulinum neurotoxin in the treatment of hemifacial spasms: a systematic review and meta-analysisBMC Neurology, 2024
- Factors influencing short-term prognosis after botulinum toxin type A treatment for hemifacial spasm:A retrospective studyHeliyon, 2024
- Hemifacial spasm through the last three decades: From etiology to efficacy and safety of long-term botulinum toxin treatmentClinical Neurology and Neurosurgery, 2021
- 2020 International Society of Hypertension Global Hypertension Practice GuidelinesHypertension, 2020
- 3D-Visualization of Neurovascular Compression at the Ventrolateral Medulla in Patients with Arterial HypertensionClinical Neuroradiology, 2020
- New insights into the pathophysiology of primary hemifacial spasmNeurochirurgie, 2018
- Primary hemifacial spasm and arterial hypertension: A multicenter case–control studyNeurology, 2000
- Vascular compression of cranial nerves: II: PathophysiologyNeurological Research, 1999
- Hemifacial spasm: Clinical findings and treatmentMuscle & Nerve, 1998
- Treatment choices of 119 patients with hemifacial spasm over 11 yearsClinical Neurology and Neurosurgery, 1996